Tandem Diabetes Care Statistics
Share Statistics
Tandem Diabetes Care has 66.61M
shares outstanding. The number of shares has increased by 2.92%
in one year.
| Shares Outstanding | 66.61M |
| Shares Change (YoY) | 2.92% |
| Shares Change (QoQ) | 1.21% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 802 |
| FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 6.38M, so 9.6% of the outstanding
shares have been sold short.
| Short Interest | 6.38M |
| Short % of Shares Out | 9.6% |
| Short % of Float | 14.76% |
| Short Ratio (days to cover) | 3.63 |
Valuation Ratios
The PE ratio is -24.55 and the forward
PE ratio is -33.71.
Tandem Diabetes Care's PEG ratio is
0.43.
| PE Ratio | -24.55 |
| Forward PE | -33.71 |
| PS Ratio | 2.51 |
| Forward PS | 1.1 |
| PB Ratio | 8.96 |
| P/FCF Ratio | 472.08 |
| PEG Ratio | 0.43 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Tandem Diabetes Care.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.93,
with a Debt / Equity ratio of 1.8.
| Current Ratio | 2.93 |
| Quick Ratio | 2.33 |
| Debt / Equity | 1.8 |
| Debt / EBITDA | -4.78 |
| Debt / FCF | 94.83 |
| Interest Coverage | -13.37 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $354,793.58 |
| Profits Per Employee | $-36,235.85 |
| Employee Count | 2,650 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 3.01 |
Taxes
| Income Tax | 4.16M |
| Effective Tax Rate | -4.52% |
Stock Price Statistics
The stock price has increased by -48.35% in the
last 52 weeks. The beta is 1.48, so Tandem Diabetes Care's
price volatility has been higher than the market average.
| Beta | 1.48 |
| 52-Week Price Change | -48.35% |
| 50-Day Moving Average | 18.87 |
| 200-Day Moving Average | 32.38 |
| Relative Strength Index (RSI) | 68.97 |
| Average Volume (20 Days) | 1,861,583 |
Income Statement
In the last 12 months, Tandem Diabetes Care had revenue of 940.2M
and earned -96.03M
in profits. Earnings per share was -1.47.
| Revenue | 940.2M |
| Gross Profit | 489.57M |
| Operating Income | -99.13M |
| Net Income | -96.03M |
| EBITDA | -99.13M |
| EBIT | -99.28M |
| Earnings Per Share (EPS) | -1.47 |
Full Income StatementBalance Sheet
The company has 69.23M in cash and 473.56M in
debt, giving a net cash position of -404.33M.
| Cash & Cash Equivalents | 69.23M |
| Total Debt | 473.56M |
| Net Cash | -404.33M |
| Retained Earnings | -1.05B |
| Total Assets | 922.14M |
| Working Capital | 375.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 24.23M
and capital expenditures -19.23M, giving a free cash flow of 4.99M.
| Operating Cash Flow | 24.23M |
| Capital Expenditures | -19.23M |
| Free Cash Flow | 4.99M |
| FCF Per Share | 0.08 |
Full Cash Flow StatementMargins
Gross margin is 52.07%, with operating and profit margins of -10.54% and -10.21%.
| Gross Margin | 52.07% |
| Operating Margin | -10.54% |
| Pretax Margin | -9.77% |
| Profit Margin | -10.21% |
| EBITDA Margin | -10.54% |
| EBIT Margin | -10.54% |
| FCF Margin | 0.53% |
